Crohn's Disease and Colitis Trial, Recruiting (NCT05636709)

Crohn's Disease and Colitis Trial, Recruiting NCT05636709 Sponsor: Adacyte Therapeutics SL Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT05636709 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older
People who have been formally diagnosed with ulcerative colitis (UC) or Crohn's disease (CD) based on recognised European medical guidelines (called ECCO criteria)
People whose treating doctor has already independently decided to start them on a treatment called GMA (granulocyte and monocyte apheresis), regardless of this study
People who understand the study and are willing to sign a consent form agreeing to take part

Who may not be able to join:

People who have a medical or psychological condition that, in the opinion of the study doctor, might make it difficult for them to follow the study procedures
People who are already taking part in another clinical trial

Important: If the study doctor believes a person may not fully understand what taking part in the study means, a legal representative would need to sign the consent form on their behalf before that person could be included (confirm with trial site).

Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jose Luis Cabriada, H. Galdakao

Phone: +34680190948

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05636709

Sponsor: Adacyte Therapeutics SL

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +34680190948

More information: https://clinicaltrials.gov/study/NCT05636709

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older
People who have been formally diagnosed with ulcerative colitis (UC) or Crohn's disease (CD) based on recognised European medical guidelines (called ECCO criteria)
People whose treating doctor has already independently decided to start them on a treatment called GMA (granulocyte and monocyte apheresis), regardless of this study
People who understand the study and are willing to sign a consent form agreeing to take part

Who may not be able to join:

People who have a medical or psychological condition that, in the opinion of the study doctor, might make it difficult for them to follow the study procedures
People who are already taking part in another clinical trial

Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Adacyte Therapeutics SL

Registry

ClinicalTrials.gov

Start date

11 January 2022

Est. completion

30 June 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Proportion of patients achieving steroid-free clinical remission at 6 months after completion of GMA therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov